Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo - PubMed (original) (raw)

Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo

P Poignard et al. Immunity. 1999 Apr.

Free article

Abstract

Neutralizing antibodies can protect against challenge with HIV-1 in vivo if present at appropriate concentrations at the time of viral challenge, but any role in the control of established infection is unclear. Here, we show that high serum concentrations of neutralizing monoclonal antibodies, either singly or as a cocktail, have little sustained effect on viral load in established HIV-1 infection in hu-PBL-SCID mice. In some instances, virus replication of neutralization-sensitive virus continues even in the presence of high levels of neutralizing antibody. In most instances, neutralization escape occurs in a few days, even from a cocktail of three antibodies that recognize distinct epitopes. The results imply that humoral immunity is unlikely to play a significant role in the control of established HIV-1 infection in humans.

PubMed Disclaimer

Similar articles

• hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120.
  Safrit JT, Fung MS, Andrews CA, Braun DG, Sun WN, Chang TW, Koup RA. Safrit JT, et al. AIDS. 1993 Jan;7(1):15-21. doi: 10.1097/00002030-199301000-00002. AIDS. 1993. PMID: 7680205
• Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.
  Gauduin MC, Parren PW, Weir R, Barbas CF, Burton DR, Koup RA. Gauduin MC, et al. Nat Med. 1997 Dec;3(12):1389-93. doi: 10.1038/nm1297-1389. Nat Med. 1997. PMID: 9396610
• Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160.
  Mosier DE, Gulizia RJ, MacIsaac PD, Corey L, Greenberg PD. Mosier DE, et al. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2443-7. doi: 10.1073/pnas.90.6.2443. Proc Natl Acad Sci U S A. 1993. PMID: 8460155 Free PMC article. Clinical Trial.
• Neutralizing antibodies mechanism of neutralization and protective activity against HIV-1.
  Xiao Y, Dong X, Chen YH. Xiao Y, et al. Immunol Res. 2002;25(3):193-200. doi: 10.1385/IR:25:3:193. Immunol Res. 2002. PMID: 12018459 Review.
• The role of neutralizing antibodies in HIV infection.
  Humbert M, Dietrich U. Humbert M, et al. AIDS Rev. 2006 Apr-Jun;8(2):51-9. AIDS Rev. 2006. PMID: 16848273 Review.

Cited by

• Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design.
  Burton DR, Hangartner L. Burton DR, et al. Annu Rev Immunol. 2016 May 20;34:635-59. doi: 10.1146/annurev-immunol-041015-055515. Annu Rev Immunol. 2016. PMID: 27168247 Free PMC article. Review.
• Post-infection immunodeficiency virus control by neutralizing antibodies.
  Yamamoto H, Kawada M, Takeda A, Igarashi H, Matano T. Yamamoto H, et al. PLoS One. 2007 Jun 20;2(6):e540. doi: 10.1371/journal.pone.0000540. PLoS One. 2007. PMID: 17579714 Free PMC article.
• Enhanced cytoplasmic sequestration of the nuclear export receptor CRM1 by NS2 mutations developed in the host regulates parvovirus fitness.
  López-Bueno A, Valle N, Gallego JM, Pérez J, Almendral JM. López-Bueno A, et al. J Virol. 2004 Oct;78(19):10674-84. doi: 10.1128/JVI.78.19.10674-10684.2004. J Virol. 2004. PMID: 15367634 Free PMC article.
• Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1.
  Zhang MY, Borges AR, Ptak RG, Wang Y, Dimitrov AS, Alam SM, Wieczorek L, Bouma P, Fouts T, Jiang S, Polonis VR, Haynes BF, Quinnan GV, Montefiori DC, Dimitrov DS. Zhang MY, et al. MAbs. 2010 May-Jun;2(3):266-74. doi: 10.4161/mabs.2.3.11416. Epub 2010 May 5. MAbs. 2010. PMID: 20305395 Free PMC article.
• The antiviral activity of antibodies in vitro and in vivo.
  Parren PW, Burton DR. Parren PW, et al. Adv Immunol. 2001;77:195-262. doi: 10.1016/s0065-2776(01)77018-6. Adv Immunol. 2001. PMID: 11293117 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information